stock
KURA · Kura Oncology, Inc.
What Kura Oncology, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live KURA price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on KURA.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 88,960,619 as of 2026-08-07 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -411.9%
- Net
- -384.3%
Returns
- ROE
- -612.8%
- ROA
- -50.5%
Health
- Current ratio
- 4.7x
- Debt/equity
- 0.2x
Deep value
- NCAV
- $20.08M
- NCAV per share
- $0.23
- Price/NCAV
- Locked
- NNWC
- -$460.79M
- NNWC per share
- -$5.18
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $20.87M | —Gross profit: unreported by this company. | -$73.01M | -$68.33M | 10-Q filed 2026-08-12 |
| 2026-03-31 | $18.27M | —Gross profit: unreported by this company. | -$78.81M | -$73.33M | 10-Q filed 2026-08-12 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $17.34M | —Gross profit: unreported by this company. | -$86.27M | -$81.00M | DEF 14A filed 2026-04-10 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $20.75M | —Gross profit: unreported by this company. | -$80.00M | -$74.12M | 10-Q filed 2025-11-04 |
| 2025-06-30 | $15.29M | —Gross profit: unreported by this company. | -$72.67M | -$66.12M | 10-Q filed 2026-08-12 |
| 2025-03-31 | $14.11M | —Gross profit: unreported by this company. | -$64.70M | -$57.43M | 10-Q filed 2026-08-12 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | — | —Gross profit: unreported by this company. | -$22.45M | -$19.22M | DEF 14A filed 2026-04-10 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | — | —Gross profit: unreported by this company. | -$59.88M | -$54.40M | 10-Q filed 2025-11-04 |
- Assets
- $587.79M
- Equity
- $48.43M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $67.48M | -$303.63M | -$278.67M | -$70.70M |
| 2024-12-31 | $53.88M | -$193.19M | -$173.98M | $133.84M |
| 2023-12-31 | $0 | -$165.80M | -$152.63M | -$124.99M |
| 2022-12-31 | — | -$139.87M | -$135.84M | -$110.69M |
| 2021-12-31 | — | — | -$130.47M | -$105.70M |
| 2020-12-31 | — | — | -$89.63M | -$72.00M |
| 2019-12-31 | — | — | -$63.14M | — |
| 2018-12-31 | — | — | -$60.45M | — |
| 2017-12-31 | — | — | -$35.43M | — |
| 2016-12-31 | — | — | -$27.56M | — |
Company filings
events
Other event
Other eventSep 98-KExecutive or director change
Executive or director changeSep 88-KResults
ResultsAug 128-KExecutive or director change
Executive or director changeJul 298-KExecutive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsJun 48-KResults
ResultsMay 128-K
5% owners ()
Montanova Capital, LLC
Stake update
Armistice Capital, LLC
Stake update
Vanguard Capital Management
Passive stake
The Vanguard Group
Stake update
Armistice Capital, LLC
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Bair Teresa Brophy
Chief Legal Officer
Sale$88,618Sep 29, 6:30 PM ET
FORD KATHLEEN
Chief Operating Officer
Sale$111,931Sep 29, 6:30 PM ET
Leoni Mollie
Chief Medical Officer
Sale$440,237Sep 29, 6:30 PM ET
DOYLE THOMAS JAMES
SVP, Finance & Accounting
Sale$48,361Sep 29, 6:30 PM ET
Powl Brian T.
Chief Commercial Officer
Sale$345,036Sep 29, 6:30 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named KURA, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about KURA.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on KURA come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the KURA board